Navigation Links
The Leukemia & Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense
Date:6/18/2009

WASHINGTON, June 18 /PRNewswire-USNewswire/ -- George Dahlman, senior vice president of public policy for The Leukemia & Lymphoma Society (LLS), testified today before the U.S. Senate Subcommittee on Defense Appropriations, calling for funding for a dedicated, stand-alone blood cancer research program at the Department of Defense (DoD).

The Institute of Medicine (IOM) has determined that several blood cancers, including chronic lymphocytic leukemia (CLL), lymphoma and multiple myeloma, are associated with exposure to chemical and biological agents from the Vietnam and two Gulf Wars. IOM has identified the need to begin a special research program that is responsive to the needs of military personal and veterans.

LLS specifically called for the funding of a collaborative public-private effort between the U.S. Military Cancer Institute, LLS and a blue ribbon panel of scientific academicians.

The USMCI has over 9 million electronic medical records detailing the health histories of service men and women and their families. The military also has serum and tissue specimens from these individuals stored as a routine step in their health care. These records and samples, together, provide a unique base that can power blood cancer research relevant to the military environment and lifestyle in a way that is not possible for any other population.

"A joint effort, tapping the expertise of both USMCI and LLS, represents a unique opportunity to identify valuable research opportunities and state-of-the-art technology that can address significant questions on the origins and diagnosis of blood cancers," according to Dahlman.

"DoD research on blood cancers addresses the importance of preparing for civilian and military exposure to the weapons being developed by several hostile nations and to aid in the march to more effective treatment for all who suffer from these diseases," Dahlman sa
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Taking Aim at Relapse of Leukemia in Kids
2. Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)
3. Study IDs benefit of donor SCT for adults with acute myeloid leukemia
4. Donor Stem-Cell Transplant Best For Acute Myeloid Leukemia
5. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
6. 5 Spanish centers join a study for a new leukemia and lymphoma treatment technique
7. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO
8. Cole Foundation injects $2.5 million to bolster leukemia research
9. Leukemia Risk From MS Drug May Be Up
10. Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought
11. Researchers find drug that inhibits acute leukemia cell growth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Since 1996, crop plants genetically modified to ...in insects, yet safe for people, have been planted...popularity of these Bt crops, named after the bact...bility to kill some major pests, allowing farmers ...reducing insecticide sprays. , However, since in...
(Date:11/23/2009)...Study found one more than doubled chances, while b... Nov. 23 (HealthDay News) -- Children whose mother...ead have more than double the risk of having atten...r children, new research shows. , And with expo...aving ADHD soared. Children whose mothers smoked d...
(Date:11/23/2009)...,, DALLAS,Nov.23/PRNewswire/--TheBerylCompani...rservicesforthehealthcareindustry,hasearnedrecogni...dernHealthcare ,theindustry,sleadingtrademagazine....gfirmsbasedonBeryl,s2008businessresults,whichenabl..., Berylattributesthisgrowthtoitsinnovativeproduct...
(Date:11/23/2009)... Information about Oxycod... launched DopeStats.com. The new site is a statist... use rates of Oxycodone in each county in the Unit...e who have used the drug for recreational or medic...FL (PRWEB) November 23, 2009 -- Legal and illegal ...
(Date:11/23/2009)... Summary: People are hire...onalities. Personality assessments give insight in...ormance. The Candidate Potential Report assesses a...summarizes the recommendation for job fit and pote...ybrook, CT (PRWEB) November 23, 2009 -- When does ...
Breaking Medicine News(10 mins):Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 3
...(FDA) has approved DORIBAX(TM),(doripenem for inje...dominal and complicated urinary tract infections, ... activity against a wide range of,Gram-positive an...cquire,bacterial infections in hospitals each year...
...es pose big stomach risks, study notes , ...s of patients don,t tell their doctors that they t...spirin and ibuprofen, a potentially dangerous omis...reasing yearly," said study lead author Dr. Raj T....
...tive African-American men could be putting their p... research in the latest UK-based Journal of Advanc...er men in the USA found that many of the 40 to 65 ...ex and 22 per cent having unsafe anal sex. The res...
...ed to contribute to heart attack, stroke and demen... vision loss, researchers say. , Homocysteine lev...blem for Americans whose diets are often poor in f...t to know the impact of resulting elevated homocys...
... More Transplant Patients and Family ...5 The National Foundation for,Transplants (NFT) a...s to,more transplant patients and families in need...is made possible by a sponsorship from,Roche which...
...nual ASRM Meeting, WASHINGTON, Oct. 15 Twelve lu... 2007 My Little Miracle Essay Contest for their,dr...ir ,little miracles,children born with the help of...follitropin for injection, purified),and/or MENOPU...
Other Medicine News:Health News:MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 3Health News:Older African-American men with HIV often have sex without condoms 2Health News:Impact of elevated homocysteine levels on vision under study 2Health News:Impact of elevated homocysteine levels on vision under study 3Health News:National Foundation for Transplants to Expand Program Providing Hotel Accommodations to Patient Families 2Health News:National Foundation for Transplants to Expand Program Providing Hotel Accommodations to Patient Families 3Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 2Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 3Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 4
(Date:11/20/2009)... 20 Cornerstone Therapeu...ical company focused on acquiring, developing and ... the respiratory and related markets, today report...Food and Drug Administration ("FDA") alleging that...Cl 10 mg, Pyrilamine Maleate 16 mg) and Deconsal D...
(Date:11/20/2009)...0 Medco Health Solutions...ansformation in American healthcare through an adv...ivering higher quality clinical care and fundament...icine smarter for the benefit of patients and payo...e elements in its strategy enable "Smarter Medicin...
(Date:11/20/2009)...v. 20 Reportlinker.com announces t...ts catalogue. ,, Global Self Monitoring Blood ...e Growth ,, http://www.reportlinker.com/p016...SMBG )-Increasing-Adoption-to-Drive-Growth.html#ut...aign=prnewswire ,, Description ,, Global ...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Prominent Health Experts Who Support Public Insurance Option Available for Interview 51507 1Prominent Health Experts Who Support Public Insurance Option Available for Interview 51507 2Prominent Health Experts Who Support Public Insurance Option Available for Interview 51507 3Prominent Health Experts Who Support Public Insurance Option Available for Interview 51507 4Prominent Health Experts Who Support Public Insurance Option Available for Interview 51507 5deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke 4719 1deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke 4719 2deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke 4719 3deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke 4719 4PALNET Solves the Pallet Buyers Dilemma 51500 1PALNET Solves the Pallet Buyers Dilemma 51500 2
...eated with VELCADE, cyclophosphamide,and predniso... /PRNewswire-FirstCall/ -- Millennium,Pharmaceutic...sults,from clinical trials of VELCADE based therap... response(1) (CR) rates in previously,treated mult...esented at the prestigious 11th International Myel...
...reases Incidence of Recurrent Wheeze by,Almost Hal...9, 2007,/PRNewswire-FirstCall/ -- Abbott and MedIm...shed in the July issue of Journal of,Pediatrics, s...),may reduce recurrent wheezing in premature infan...d that premature infants without,chronic lung dise...
Other Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
Cholesterol Reagent
Omega 16ic
...high performance bio imaging system for chemilumin...es the process of imaging chemiluminescent samples...remely easy to use, thanks to new, unique image an...ased on the standard Genegnome, the Genegnome HR h...
...let aggregometers allows to choose the instrument ...l and four sample units are available, with chart ...ddition to the Chrono-log Optical aggregometers, w...-plasma (PRP), Chrono-log supplies: Whole blood ag...
Medicine Products: